title_organisation_en

This version is for browsers with a low level of support for CSS, and is des

Biotechnology and Life Sciences in Baden-Württemberg

Logo state of Baden-Württemberg

Home Language Selection


Home Content Area

Home Navigator

You are here:

End Navigator



Health

teaser_img
© Hainmüller/Bartos, University of Freiburg

About synapses and learning

You can’t teach an old dog new tricks – the old proverb is not totally true. It is now known that the modulation of synaptic functions, including the formation of new neurons, still takes place in old age, although to a lesser extent than in childhood. Physician Thomas Hainmüller and Prof. Dr. Marlene Bartos from the Institute of Physiology at the University of Freiburg are investigating mechanisms that are the basis for long-term memory formation and have found that the inhibitory interneurons in the hippocampus play an important role.
more
Science

teaser_img

Cell and gene therapies: from bench to bedside

teaser_img
© dkfz
While cell therapy has become standard treatment for a number of blood cancers, most cell and gene therapy approaches for the treatment of hereditary and metabolic diseases, neurodegenerative disorders and cancer are still in the experimental phases or early clinical trials. However, recent successes give rise to the hope that cell and gene therapies will in future make important contributions to previously incurable diseases.
more

Industrial Biotechnology

Six Months Research at the other Side of the World

teaser_img
A fellowship program funded by the Baden-Württemberg Ministry of Science, Research and the Arts enabled Sonja Blasche to spend six months at the Minhang Campus of the Jiao Tong University in Shanghai. During this time she worked in the laboratory of Professor Zhao Liping, an internationally known expert on microbial communities and the human gut microbiota. Read more about her experiences in China in the following article.
more
Retrospective

IMI 2: Ebola and other filoviral haemorrhagic fevers programme

teaser_img
The topics of the proposed Innovative Medicines Initiative 2 (IMI 2) Ebola and other filoviral haemorrhagic fevers programme (the Ebola+ programme) cover actions that will address short term challenges of the current epidemic as well as actions needed to address EVD and other filoviral haemorrhagic fevers in a sustainable way for the long-term. Submission deadline is 1 December 2014 at 17:00 CET.
more

Biotechnology in Baden-Württemberg on YouTube


You can't spell it, but you can... 
Image-Video You cant`t spell ist, but you can... Baden-Württemberg (externer Link, neues Fenster)

Events

JobMarket


Jobs in Baden-Württemberg

RSS-Feeds

SEARCH


DATABASE

for Companies and Research Institutions



NEWSLETTER


GLOSSARY

All biological terms with explanation




http://www.cluster-biopolymere.de/index.html?lang=en